Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

NCT03508739 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

25

Enrollment

OTHER

Sponsor class

Stopped We do not have active funding at this time.

Conditions

Diabetes Mellitus, Type 2
Pre-diabetic
Hypertension
Elevated Blood Pressure

Interventions

DRUG: Sacubitril/Valsartan 200mg (blinded)
DRUG: Valsartan 160mg (blinded)

Sponsor

University of Pennsylvania